Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate physiological and physical performance effects in ADHD
PACTR202011697726048Suspended
- Sponsor
- National Lottery Distribution Trust Fund
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by National Lottery Distribution Trust Fund. Primary endpoints: ECG, cardiorespiratory fitness and 5 more. Started Feb 2020; status: suspended.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on PACTR202011697726048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202011697726048.